BTG acquires U.S. commercial rights to Wellstat Therapeutics' candidate for overexposure to 5-FU July 7, 2011
Rib-X Pharmaceuticals and Sanofi enter collaboration to develop new classes of antibiotics July 6, 2011
Antisense Therapeutics grants exclusive option to license anticancer compound ATL-1101 to Afandin July 5, 2011
Tibotec and Gilead Sciences enter license agreement for fixed-dose antiretroviral combination tablet July 4, 2011
RSS